Important note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date.
 |
New Vision (Kampala) - October 5, 2005
Jude Etyang
The commission wants the intended beneficiaries of GFATM-funded projects to see the list and provide evidence on whether the money was properly used, the secretary, Andrew Kasirye, said.
Kasirye said the list of the 300 sub-recipients would be published on Friday and that thereafter, witnesses would be expected to testify at the public hearings of the commission.
"We want the beneficiaries to come forward to justify or challenge whether the money was disbursed," Kasirye said yesterday.
He added, "There are people who took the money and put it to illegal use. people should come out to confirm whether the projects were undertaken or not." The recipients include district councils, civil society organisations, lead agencies and direct implementers. The funds were meant to support AIDS treatment and to facilitate voluntary counselling and testing.
It was also meant to provide long-lasting bed nets, new artemisinin-based combination therapy treatments for malaria and treatment against tuberculosis.
Among the commission's terms of reference is the investigation of PMU's selection of sub-recipients and their competence.
The commission will also investigate the Project Management Unit (PMU) failure to follow up sub-recipients who did not account for their funds.
The Global Fund last month suspended grants to Uganda after learning of "serious mismanagement" of funds by PMU. The commission will also probe allegations that expenditure of the PMU contravened Fund procedure.
051005
NV051004
Copyright © 2005 - The New Vision. All articles are republished on AEGIS by permission. Material may not be redistributed, posted to any other location, published or used for broadcast without written authorization from Managing Director/Editor-in-chief, The New Vision, P.O. Box 9815, Kampala - Uganda, Tel/fax: 256-41-235221, E-mail: wpike@newvision.co.ug.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .